-- Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher Bio -- Follows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine release -- Commit is poised to ...

Add Yahoo as a preferred source to see more of our stories on Google. That’s the major takeaway from a new study published in the journal Science. For the study, researchers followed 113 patients with ...

Undertaking a study of proteins found in the complement system, an important part of the immune system, of patients with long COVID, researchers have identified a blood protein ‘signature’ that may ...

Dianthus achieved its NASDAQ listing last year via a merger with Magenta Therapeutics. The company is focused on development of a single drug candidate, DNTH-103, which targets the complement system, ...

A new study may have found what’s behind long COVID symptoms. Scientists say a portion of the immune system may stay activated after someone recovers from the virus. Research into what causes long ...

The story of Q32 Bio, a company that develops therapeutics for inflammatory and autoimmune diseases, started two decades ago. That's when V. Michael Holers, MD, a University of Colorado School of ...

Our immune system is armed with an array of defenses designed to detect and eliminate harmful threats. One of its most powerful defense mechanisms is the complement system-a group of proteins that ...

Long COVID has mystified the medical community for years, making it a tough condition to diagnose, let alone treat. However, a growing body of research has found more information on what may be behind ...